Joel Patrick Schneider

This inventor holds 10 USPTO granted patents and 3 published patent applications and 2 EPO patents. Top assignees: The United States of America, as Represented by the Secretary, Department of Health and Human Services, University of Delaware, Johns Hopkins University. Active years: 2010-2026.

USPTO Granted Patents = 10 (Patent Applications = 3)

% Patents Active = 90.0

EPO Patents = 2 (Patent Applications = 1)

Average Co-Inventor Count = 3.3

ph-index = 2

Forward Citations = 18(Granted Patents)

Location History:

Newark, DE (US) (2010 - 2012)
Middletown, MD (US) (2013 - 2018)
Frederick, MD (US) (2022 - 2024)

Company Filing History:

5 out of 3,688

The United States of America, as Represented by the Secretary, Department of Health and Human Services

patents

4 out of 442

University of Delaware

patents

3 out of 3,794

Johns Hopkins University

patents

4. 1 out of 22

Kennedy Krieger Institute, Inc.

patents

5. 1 out of 1,338

The Penn State Research Foundation

patents

where one patent can have more than one assignee

Years Active: 2010-2026

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12527870 - PEPTIDE HYDROGELS FOR DELIVERY OF IMMUNOSUPPRESSIVE DRUGS AND USES THEREOF (2026-01-20),

2. 12064514 - Ultrasound-sensitive peptide particles for spatially resolved molecule delivery (2024-08-20),

3. 11904057 - Nanoparticle-hydrogel composite for nucleic acid molecule delivery (2024-02-20),

4. 11661439 - Peptide hydrogels and use thereof (2023-05-30),

5. 11235075 - Peptide hydrogels generating chemical exchange saturation transfer MRI contrast and uses thereof (2022-02-01),

6. 10086108 - Hydrogels and use thereof in anastomosis procedures (2018-10-02),

7. 8426559 - [object Object] (2013-04-23),

8. 8221773 - Hydrogels and uses thereof (2012-07-17),

9. 7884185 - Hydrogels and uses thereof (2011-02-08),

10. 7858585 - Hydrogels and uses thereof (2010-12-28),

Title: Innovations of Joel Patrick Schneider

Introduction

Joel Patrick Schneider is an accomplished inventor based in Frederick, MD (US). He holds a total of 10 patents that reflect his significant contributions to the field of biomedical engineering and drug delivery systems. His work focuses on innovative methods for delivering therapeutic agents using advanced peptide technologies.

Latest Patents

One of his latest patents is titled "Ultrasound-sensitive peptide particles for spatially resolved molecule delivery." This invention involves peptisomes, including nanopeptisomes, which have a perfluorocarbon liquid core containing a therapeutically active agent. The amphiphilic peptide molecules surrounding the core are designed to facilitate the delivery of the cargo to cells, whether in vitro, ex vivo, or in vivo. Another notable patent is "Nanoparticle-hydrogel composite for nucleic acid molecule delivery." This disclosure presents novel peptide hydrogels that encapsulate nanoparticles containing nucleic acid molecules, allowing for controlled delivery through phase transitions.

Career Highlights

Throughout his career, Joel has worked with prestigious institutions such as the University of Delaware and the National Institutes of Health, a component of the US Department of Health & Human Services. His research has significantly advanced the understanding and application of peptide-based delivery systems in medicine.

Collaborations

Joel has collaborated with notable colleagues, including Darrin J Pochan and Bulent Ozbas, contributing to the development of innovative solutions in his field.

Conclusion

Joel Patrick Schneider's work exemplifies the intersection of innovation and practical application in the biomedical field. His patents and collaborations highlight his commitment to advancing therapeutic delivery methods, making a lasting impact on healthcare.